Fig. 2From: MYCN amplification predicts poor prognosis based on interphase fluorescence in situ hybridization analysis of bone marrow cells in bone marrow metastases of neuroblastomaThe prognostic significance of MYCN amplification in bone marrow metastatic NB. a, b Event free survival (EFS) and overall survival (OS) of 81 patients stratified by MYCN statusBack to article page